Calcitriol attenuates cardiac remodeling and dysfunction in a murine model of polycystic ovary syndrome (Q40310971)

19 September 2017

Calcitriol attenuates cardiac remodeling and dysfunction in a murine model of polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

19 September 2017

1 reference

1 reference

Ling Gao

1

1 reference

19 September 2017

Jia-Tian Cao

2

1 reference

19 September 2017

Yan Liang

3

1 reference

19 September 2017

Yi-Chao Zhao

4

1 reference

19 September 2017

Xian-Hua Lin

5

1 reference

19 September 2017

Xiao-Cui Li

6

1 reference

19 September 2017

Ya-Jing Tan

7

1 reference

19 September 2017

Jing-Yi Li

8

1 reference

19 September 2017

Cheng-Liang Zhou

9

1 reference

19 September 2017

Hai-Yan Xu

10

1 reference

19 September 2017

Jian-Zhong Sheng

11

1 reference

19 September 2017

He-Feng Huang

12

1 reference

19 September 2017

17 November 2015

1 reference

19 September 2017

1 reference

19 September 2017

52

1 reference

19 September 2017

2

1 reference

19 September 2017

363-373

1 reference

https://scigraph.springernature.com/pub.10.1007/s12020-015-0797-1

19 September 2017

0 references

cites work

Polycystic ovary syndrome: etiology, pathogenesis and diagnosis

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

The management of patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Cardiometabolic aspects of the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Reduced estradiol-induced vasodilation and poly-(ADP-ribose) polymerase (PARP) activity in the aortas of rats with experimental polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Lower-limb veins are thicker and vascular reactivity is decreased in a rat PCOS model: concomitant vitamin D3 treatment partially prevents these changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the Coronary Artery Risk Development in Young Adults Women's study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Dihydrotestosterone deteriorates cardiac insulin signaling and glucose transport in the rat model of polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Vitamin D receptor activation protects against myocardial reperfusion injury through inhibition of apoptosis and modulation of autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Paricalcitol downregulates myocardial renin-angiotensin and fibroblast growth factor expression and attenuates cardiac hypertrophy in uremic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Reproductive and metabolic phenotype of a mouse model of PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Effects of vitamin D3 derivative--calcitriol on pharmacological reactivity of aortic rings in a rodent PCOS model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Activation of liver-X-receptor α but not liver-X-receptor β protects against myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

RXR agonists inhibit oxidative stress-induced apoptosis in H9c2 rat ventricular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Vitamin D and vitamin D receptor activators in treatment of hypertension and cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Age, sex, and hypertension-related remodeling influences left ventricular torsion assessed by tagged cardiac magnetic resonance in asymptomatic individuals: the multi-ethnic study of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Macrophage migration inhibitory factor deletion exacerbates pressure overload-induced cardiac hypertrophy through mitigating autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

The AMPK signalling pathway coordinates cell growth, autophagy and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

1,25-dihydroxyvitamin D3 reduces systolic blood pressure in hypertensive adults: a pilot feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

p62 at the crossroads of autophagy, apoptosis, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

AMPK attenuates microtubule proliferation in cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt/mTOR and NFκB signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Gene targeting by the vitamin D response element binding protein reveals a role for vitamin D in osteoblast mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

SH2B1 is critical for the regulation of cardiac remodelling in response to pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-015-0797-1

Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes?

21 January 2018

1 reference

12 December 2020

Cardiac fatty acid uptake and metabolism in the rat model of polycystic ovary syndrome.

1 reference

12 December 2020

Role of vitamin D in the cardiac remodeling induced by tobacco smoke exposure

1 reference

12 December 2020

Autophagy in Myocardial Differentiation and Cardiac Development

1 reference

12 December 2020

Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women

1 reference

12 December 2020

Internal carotid artery haemodynamics in women with polycystic ovaries.

1 reference

12 December 2020

Biochemical hyperandrogenism is associated with metabolic syndrome independently of adiposity and insulin resistance in Romanian polycystic ovary syndrome patients

1 reference

12 December 2020

The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload

1 reference

12 December 2020

10.1007/S12020-015-0797-1

Identifiers

DOI

1 reference

Dimensions Publication ID

19 September 2017

0 references

1 reference